The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 1×
“There will hopefully be discoveries of individual key cancer genes, with major diagnostic and therapeutic opportunities, as illustrated by the discovery of the BRAF oncogene”
BackgroundGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527 · cited 1×
“One of the mechanisms leading to drug resistance is the emergence of secondary EGFR mutations such as the threonine substitution of methionine at position 790 (Thr790Met)”
BackgroundGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
Network‐based classification of breast cancer metastasis
Chuang, H., Lee, E., Liu, Y., Lee, D., & Ideker, T. (2007) · Molecular Systems Biology · doi:10.1038/msb4100180 · Cited by 1,431
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
Baccarani, M., Cortes, J., Pane, F., Niederwieser, D., Saglio, G., Apperley, J., Cervantes, F., Deininger, M., Gratwohl, A., Guilhot, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0779 · Cited by 1,291
Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,190
Ng, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M., & Sung, J. J. Y. (2009) · Gut · doi:10.1136/gut.2008.167817 · Cited by 1,151 · cited 1×
“In another study of colorectal cancer, miR-17-3p and miR-92 were elevated in the plasma of patients before surgery and reduced after surgery in a subgroup of patients”
BackgroundCirculating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
An integrative genomics approach to infer causal associations between gene expression and disease
Schadt, E. E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S. K., Monks, S., Reitman, M., Zhang, C., et al. (2005) · Nature Genetics · doi:10.1038/ng1589 · Cited by 1,043 · cited 1×
“The feasibility of building such causal models has been demonstrated by integrating data from genetic, gene-expression and clinical data in a likelihood-based causality model, which yielded candidate genes predicted to be causal for obesity that were later validated in knockout mouse models”
BackgroundMoore, R. G., McMeekin, D. S., Brown, A. K., DiSilvestro, P., Miller, M. C., Allard, W. J., Gajewski, W., Kurman, R., Bast, R. C., & Skates, S. J. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.031 · Cited by 875
Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.
Kaneko, M., Eguchi, K., Ohmatsu, H., Kakinuma, R., Naruke, T., Suemasu, K., & Moriyama, N. (1996) · Radiology · doi:10.1148/radiology.201.3.8939234 · Cited by 831
Sequist, L. V., Martins, R. G., Spigel, D., Grunberg, S. M., Spira, A., Jänne, P. A., Joshi, V. A., McCollum, D., Evans, T. L., Muzikansky, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8494 · Cited by 820 · cited 1×
“While EGFR tyrosine kinase inhibitor therapy has led to dramatically improved response rates in patients with NSCLC with activating EGFR mutations, the response is often short lived with most patients experiencing tumor progression within 1 year of therapy”
BackgroundCirculating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 717
Lung Cancer Screening with CT: Mayo Clinic Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Sloan, J. A., Sykes, A.-M., Aughenbaugh, G. L., & Clemens, M. A. (2003) · Radiology · doi:10.1148/radiol.2263020036 · Cited by 665
Pantel, K., Alix-Panabières, C., & Riethdorf, S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.44 · Cited by 643
CT Screening for Lung Cancer: Five-year Prospective Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Mandrekar, S. J., Hillman, S. L., Sykes, A.-M., Aughenbaugh, G. L., Bungum, A. O., & Allen, K. L. (2005) · Radiology · doi:10.1148/radiol.2351041662 · Cited by 636
Zhu, J., Zhang, B., Smith, E. N., Drees, B., Brem, R. B., Kruglyak, L., Bumgarner, R. E., & Schadt, E. E. (2008) · Nature Genetics · doi:10.1038/ng.167 · Cited by 564
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Leary, R. J., Kinde, I., Diehl, F., Schmidt, K., Clouser, C., Duncan, C., Antipova, A., Lee, C., McKernan, K., De La Vega, F. M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000702 · Cited by 517
Screening for Early Lung Cancer with Low-Dose Spiral CT: Prevalence in 817 Asymptomatic Smokers
Diederich, S., Wormanns, D., Semik, M., Thomas, M., Lenzen, H., Roos, N., & Heindel, W. L. (2002) · Radiology · doi:10.1148/radiol.2223010490 · Cited by 501
Sone, S., Li, F., Yang, Z.-G., Honda, T., Maruyama, Y., Takashima, S., Hasegawa, M., Kawakami, S., Kubo, K., Haniuda, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1531 · Cited by 495
Pastorino, U., Bellomi, M., Landoni, C., De Fiori, E., Arnaldi, P., Picchio, M., Pelosi, G., Boyle, P., & Fazio, F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14188-8 · Cited by 452
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
Cortez, M. A., & Calin, G. A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902932889 · Cited by 436
Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung
Raponi, M., Zhang, Y., Yu, J., Chen, G., Lee, G., Taylor, J. M. G., MacDonald, J., Thomas, D., Moskaluk, C., Wang, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1191 · Cited by 435
Fan, T. W., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., & Miller, D. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-41 · Cited by 434
Brichory, F. M., Misek, D. E., Yim, A.-M., Krause, M. C., Giordano, T. J., Beer, D. G., & Hanash, S. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171320598 · Cited by 353
Self-citationSerum autoantibodies as biomarkers for early cancer detection
Tan, H. T., Low, J., Lim, S. G., & Chung, M. C. M. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07396.x · Cited by 315
Lung Cancer Screening Using Low-Dose Spiral CT
Nawa, T., Nakagawa, T., Kusano, S., Kawasaki, Y., Sugawara, Y., & Nakata, H. (2002) · Chest · doi:10.1378/chest.122.1.15 · Cited by 315
Taguchi, F., Solomon, B., Gregorc, V., Roder, H., Gray, R., Kasahara, K., Nishio, M., Brahmer, J., Spreafico, A., Ludovini, V., et al. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk195 · Cited by 312
Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks
Yang, X., Deignan, J. L., Qi, H., Zhu, J., Qian, S., Zhong, J., Torosyan, G., Majid, S., Falkard, B., Kleinhanz, R. R., et al. (2009) · Nature Genetics · doi:10.1038/ng.325 · Cited by 288
Shames, D. S., Girard, L., Gao, B., Sato, M., Lewis, C. M., Shivapurkar, N., Jiang, A., Perou, C. M., Kim, Y. H., Pollack, J. R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030486 · Cited by 262
Li, F., Sone, S., Abe, H., MacMahon, H., & Doi, K. (2004) · Radiology · doi:10.1148/radiol.2333031018 · Cited by 252
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Alunni-Fabbroni, M., & Sandri, M. T. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.027 · Cited by 250
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5392 · Cited by 247
Metabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications
Claudino, W. M., Quattrone, A., Biganzoli, L., Pestrin, M., Bertini, I., & Di Leo, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7550 · Cited by 246
Molecular mechanisms of metastasis in breast cancer—clinical applications
Mego, M., Mani, S. A., & Cristofanilli, M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.171 · Cited by 235
Jentzmik, F., Stephan, C., Miller, K., Schrader, M., Erbersdobler, A., Kristiansen, G., Lein, M., & Jung, K. (2010) · European Urology · doi:10.1016/j.eururo.2010.01.035 · Cited by 234
Brichory, F., Beer, D., Naour, F. L., Giordano, T. J., & Hanash, S. (2001) · PubMed · Cited by 230
Self-citationKimura, H., Suminoe, M., Kasahara, K., Sone, T., Araya, T., Tamori, S., Koizumi, F., Nishio, K., Miyamoto, K., Fujimura, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603949 · Cited by 205
Fujiwara, K., Fujimoto, N., Tabata, M., Nishii, K., Matsuo, K., Hotta, K., Kozuki, T., Aoe, M., Kiura, K., Ueoka, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1219.11.3 · Cited by 204
McBride, D. J., Orpana, A. K., Sotiriou, C., Joensuu, H., Stephens, P. J., Mudie, L. J., Hämäläinen, E., Stebbings, L. A., Andersson, L. C., Flanagan, A. M., et al. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20815 · Cited by 196
Self-citationOccurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera
Qiu, J., Choi, G., Li, L., Wang, H., Pitteri, S. J., Pereira-Faca, S. R., Krasnoselsky, A. L., Randolph, T. W., Omenn, G. S., Edelstein, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2388 · Cited by 184
Self-citationMetabolomics: Moving to the Clinic
Nordström, A., & Lewensohn, R. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9156-4 · Cited by 163
Biomarkers for the lung cancer diagnosis and their advances in proteomics
Sung, H.-J., & Cho, J.-Y. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.9.615 · Cited by 161
Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening
Croswell, J. M., Baker, S. G., Marcus, P. M., Clapp, J. D., & Kramer, B. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00007 · Cited by 156
Kumar, S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062893 · Cited by 154
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
Kulasingam, V., Pavlou, M. P., & Diamandis, E. P. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2831 · Cited by 151
International Cancer Genome Consortium
Berger, D. (2013) · Im Focus Onkologie · doi:10.1007/s15015-013-0268-6 · Cited by 148
Maire, F., Micard, S., Hammel, P. R., Voitot, H., Lévy, P., Cugnenc, P., Ruszniewski, P. B., & Laurent‐Puig, P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600475 · Cited by 142
Multiplexed microsphere-based flow cytometric immunoassays for human cytokines
Kellar, K. L., & Douglass, J. P. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00248-5 · Cited by 126
DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Shivapurkar, N., & Gazdar, A. F. (2010) · Current Molecular Medicine · doi:10.2174/156652410790963303 · Cited by 117
Circulating Nucleic Acids as a Potential Source for Cancer Biomarkers
Vlassov, V. V., Laktionov, P. P., & RYKOVA, E. Y. (2010) · Current Molecular Medicine · doi:10.2174/156652410790963295 · Cited by 106
Serkova, N. J., & Glunde, K. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-811-9_20 · Cited by 99
Fujiwara, H., Melenhorst, J. J., Ouriaghli, F. E., Kajigaya, S., Grube, M., Sconocchia, G., Rezvani, K., Price, D. A., Hensel, N. F., Douek, D. C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2363 · Cited by 98
Hanrahan, E. O., Ryan, A. J., Mann, H., Kennedy, S. J., Langmuir, P. B., Natale, R. B., Herbst, R. S., Johnson, B. E., & Heymach, J. V. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2568 · Cited by 88
Chen, C.-C., Chang, T.-W., Chen, F., Hou, M., Hung, S.-Y., Chong, I., Lee, S., Zhou, T., & Lin, S. (2006) · Oncology · doi:10.1159/000098557 · Cited by 84
Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection
Yee, J., Sadar, M. D., Sin, D. D., Kuzyk, M. A., Xing, L., Kondra, J., McWilliams, A. M., Man, S. F. P., & Lam, S. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4233 · Cited by 79
Kasahara, K., Arao, T., Sakai, K., MATSUMOTO, K. Y., Sakai, A., Kimura, H., Sone, T., Horiike, A., Nishio, M., Ohira, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0383 · Cited by 78
Jian, G., Zhou, S., Ling, Z., Qinfang, D., Jie, Z., Liang, T., & Caicun, Z. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0785-z · Cited by 70
Cost of Breast-Related Care in the Year Following False Positive Screening Mammograms
Chubak, J., Boudreau, D. M., Fishman, P. A., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181e57918 · Cited by 66
Amann, J. M., Lee, J., Röder, H., Brahmer, J. R., González, A., Schiller, J. H., & Carbone, D. P. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c8cbd9 · Cited by 66
Mutation-associated fusion cancer genes in solid tumors
Kaye, F. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0135 · Cited by 61
Chung, C. H., Seeley, E. H., Röder, H., Grigorieva, J., Tsypin, M., Roder, J., Burtness, B. A., Argiris, A. E., Forastiere, A. A., Gilbert, J., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0937 · Cited by 61
Dianxu, F., Shengdao, Z., Tianquan, H., Yu, J., Ruoqing, L., Zurong, Y., & Wang, X. (2002) · Pancreas · doi:10.1097/00006676-200211000-00003 · Cited by 59
Marchese, R., Muleti, A., Pasqualetti, P., Bucci, B., Stigliano, A., Brunetti, E., Angelis, M. D., Mazzoni, G., Tocchi, A., & Brozzetti, S. (2006) · Pancreas · doi:10.1097/01.mpa.0000202938.63084.e3 · Cited by 53
ChangXin, S., Hu, L., Lin, X., & Li, Y. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.10.016 · Cited by 50
Fleischhacker, M., & Schmidt, B. (2010) · Cancer Biomarkers · doi:10.3233/cbm-2009-0131 · Cited by 29
Wooster, R. F. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80006-5 · Cited by 23
Fujiwara, Y., Kiura, K., Toyooka, S., Hotta, K., Tabata, M., Takigawa, N., Soh, J., Tanimoto, Y., Kanehiro, A., Kato, K., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.07.018 · Cited by 20
Karihtala, P., Maenpaa, J. U., Turpeenniemi-Hujanen, T. M., & Puistola, U. (2010) · PubMed · Cited by 16
Cited by
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Assessing sample and miRNA profile quality in serum and plasma or other biofluids
Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M., & Dahlsveen, I. K. (2013) · Methods · doi:10.1016/j.ymeth.2012.09.015 · Cited by 687
The human circadian metabolome
Dallmann, R., Viola, A. U., Tarokh, L., Cajochen, C., & Brown, S. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114410109 · Cited by 566
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Allin, K. H., & Nordestgaard, B. G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.599831 · Cited by 553
Circulating miRNA Biomarkers for Alzheimer's Disease
Kumar, P., Dezso, Z., MacKenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., & Oda, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069807 · Cited by 381
Metadata
- Authors
- Hanash, S. M., Baik, C. S., & Kallioniemi, O.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2011-03
- Volume
- 8
- Issue
- 3
- Pages
- 142-150
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2108309679
- Cited by
- 328
- References
- 84
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.